Softwr

Research · head to head

OpenEye, Cadence Molecular Sciences vs Suzy

OpenEye, Cadence Molecular Sciences logo

OpenEye, Cadence Molecular Sciences

Research

Computational chemistry toolkits and the Orion cloud platform, now inside Cadence

From
On request
Rated
-
Full reviewWebsite
Suzy logo

Suzy

Research

Enterprise consumer insights on an owned US panel, resold elsewhere through Cint

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: OpenEye, Cadence Molecular Sciences the free Public Domain Research Licence requires surrendering intellectual property rights and publishing results into the public domain, which rules it out for any academic group with a technology transfer office or patent ambitions.; Suzy the proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
  • They diverge on capability: OpenEye, Cadence Molecular Sciences covers OMEGA, Suzy covers Suzy Insights.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which OpenEye, Cadence Molecular Sciences and Suzy actually diverge.

Attributes where OpenEye, Cadence Molecular Sciences and Suzy differ
AttributeOpenEye, Cadence Molecular SciencesSuzy
PlatformsLinux, Windows, macOS, Web, APIWeb, iOS, Android

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in OpenEye, Cadence Molecular Sciences

  • OMEGA
  • ROCS
  • ROCS X
  • Orion platform
  • Programmatic toolkits
  • Academic routes
  • Structure preparation
  • Docking and scoring

Only in Suzy

  • Suzy Insights
  • Suzy Live
  • Suzy Audiences
  • Suzy Speaks
  • Video open ends
  • Advanced methods
  • Data Explorer
  • AI Decision Engine

What people use each for

The jobs each tool is most often brought in to do.

OpenEye, Cadence Molecular Sciences

  • A pharmaceutical discovery team screening a multi-billion compound library by three-dimensional shape rather than by two-dimensional similaritynot Suzy
  • A computational chemist embedding conformer generation into an internal pipeline through the Python toolkitsnot Suzy
  • A university group publishing openly that can accept the public domain licence terms in exchange for zero costnot Suzy
  • A biotech scaling virtual screening on cloud compute without building its own clusternot Suzy

Suzy

  • A US consumer packaged goods brand that needs concept testing back the same day because a packaging decision is due at the end of the week.not OpenEye, Cadence Molecular Sciences
  • An insights department running an always-on brand tracker on a US audience without re-commissioning fieldwork every wave.not OpenEye, Cadence Molecular Sciences
  • A team that wants quant screening followed immediately by moderated qual with the same respondents, rather than two vendors and two timelines.not OpenEye, Cadence Molecular Sciences
  • A product team testing claims and price sensitivity with MaxDiff and conjoint on a panel they can go back to repeatedly.not OpenEye, Cadence Molecular Sciences

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

OpenEye, Cadence Molecular Sciences

  • The free Public Domain Research Licence requires surrendering intellectual property rights and publishing results into the public domain, which rules it out for any academic group with a technology transfer office or patent ambitions.
  • Free academic licences are renewable but re-evaluated annually with no guarantee of continuation, so a multi-year research programme has no assured software entitlement beyond the current year.
  • OpenEye now sits inside Cadence Design Systems, whose core business is chip design, so the roadmap and licensing culture are set by a company for which molecular sciences is one growth line among several.
  • Commercial pricing is entirely unpublished and structured as annual subscriptions with separate Orion compute, making total cost of a screening programme hard to forecast before contracting.
  • The toolkits assume real computational chemistry expertise; they are libraries and applications for specialists, not an interface a medicinal chemist can drive without training.

Suzy

  • The proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
  • Customers have asked Suzy to build proprietary panels with native speakers in Germany, France, Japan, India and Brazil, which confirms those do not exist today; multi-market brands need a second vendor and lose the single-source comparison.
  • Reviewers report the panel skews female and millennial and falls short on Gen Z, male and various ethnic segments, and that niche or B2B audiences are hard to reach, so quota fills can be slow or impossible.
  • Reviewers also raise data trust concerns about respondent sourcing and vetting, including one naming bot responses and acquiescence bias, which is the standing risk of any single owned opt-in panel with repeat respondents.
  • Pricing is a sales-led annual commitment reported to run around $88,000 a year at the median with onboarding fees and per-seat charges on top, with no trial, no self-serve and no pay-per-response option, so there is no cheap way to validate fit.
  • Credits are pre-committed monthly against forecast activity with no published overage rate, so under-use is wasted spend and a busy quarter triggers an unbudgeted purchase.
  • Integrations are genuinely thin: there is no public integrations page and no public API documentation, and the only confirmed external data relationship is Cint, so expect to move data by export.

Pricing, plan by plan

OpenEye, Cadence Molecular Sciences

On request
  • Commercial licence$undefined/year
    • Annual subscription priced through Cadence sales
    • Toolkits and applications licensed separately from the Orion platform
    • Orion compute billed on top of software entitlements
  • Academic Package$undefined/year
    • Paid annual subscription for university groups under ten members
    • Includes support
    • Researchers retain intellectual property rights
  • Public Domain Research LicenceFree
    • No cost
    • No support of any kind
    • No intellectual property rights retained

Suzy

On request
  • Suzy$undefined/year
    • Annual subscription with pre-committed monthly research credits
    • Credit volume set against forecast study activity
    • Onboarding fees and per-seat charges quoted separately

Which should you pick?

Choose OpenEye, Cadence Molecular Sciences if

  • You need omega.
  • You work on Linux, Windows, macOS, Web, API.
  • You also want rocs.
OpenEye, Cadence Molecular Sciences review

Choose Suzy if

  • You need suzy insights.
  • You work on Web, iOS, Android.
  • You also want suzy live.
Suzy review

Questions people ask

Is OpenEye, Cadence Molecular Sciences or Suzy better?
Neither clearly leads. OpenEye, Cadence Molecular Sciences starts at On request and Suzy at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, OpenEye, Cadence Molecular Sciences or Suzy?
OpenEye, Cadence Molecular Sciences starts at On request and Suzy at On request.
Does OpenEye, Cadence Molecular Sciences or Suzy run on more platforms?
OpenEye, Cadence Molecular Sciences runs on Linux, Windows, macOS, Web, API. Suzy runs on Web, iOS, Android.
What is OpenEye, Cadence Molecular Sciences best used for?
OpenEye, Cadence Molecular Sciences is most often used for a pharmaceutical discovery team screening a multi-billion compound library by three-dimensional shape rather than by two-dimensional similarity, a computational chemist embedding conformer generation into an internal pipeline through the python toolkits, a university group publishing openly that can accept the public domain licence terms in exchange for zero cost, a biotech scaling virtual screening on cloud compute without building its own cluster. Of those, a pharmaceutical discovery team screening a multi-billion compound library by three-dimensional shape rather than by two-dimensional similarity and a computational chemist embedding conformer generation into an internal pipeline through the python toolkits are not what Suzy is typically brought in for.
What can OpenEye, Cadence Molecular Sciences do that Suzy cannot?
OpenEye, Cadence Molecular Sciences covers OMEGA, ROCS, ROCS X, Orion platform. Suzy covers Suzy Insights, Suzy Live, Suzy Audiences, Suzy Speaks.

Answered from the vendors’ own pages

OpenEye, Cadence Molecular Sciences: Is OpenEye still OpenEye?

It trades as OpenEye, Cadence Molecular Sciences, and is part of Cadence Design Systems following acquisition. The product names OMEGA, ROCS and Orion continue.

Suzy: Is the panel global?

No. Crowdtap, the owned panel, is US only. International studies run on Cint supply, which you could contract for directly.

OpenEye, Cadence Molecular Sciences: Can academics use it for free?

Yes, through the Public Domain Research Licence or a Teaching Licence, but both come with no support and no intellectual property rights. Keeping IP rights and support requires the paid Academic Package.

Suzy: What does it cost?

Nothing is published. Third-party analysis puts the median contract around $88,000 a year with a range roughly $34,000 to $187,500, plus onboarding and per-seat fees.

OpenEye, Cadence Molecular Sciences: What is ROCS X?

A machine learning enabled extension of ROCS shape search, built on the Orion platform, aimed at screening chemical spaces in the trillions of molecules.

Suzy: Is there an API?

Nothing public. Suzy publishes no API documentation and no named connectors beyond Cint. Verify any integration requirement in the sales call before committing.

OpenEye, Cadence Molecular Sciences: Is commercial pricing published?

No. Commercial licences are annual subscriptions quoted through Cadence sales, with Orion compute charged separately.

Suzy: What changed in April 2026?

Suzy repositioned as an AI Decision Engine with Intelligence and Impact modules, while headcount fell from about 230 to 186. Ask how the roadmap is now split between that and the classic survey and qual products.

Share

Related pages

More on OpenEye, Cadence Molecular Sciences

More on Suzy

Keep looking

Other head to heads